Press Release – New York, NY – July 8, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented BioSig Technologies, Inc. (Nasdaq: BSGM), which recently merged with Streamex Exchange Corporation, in its definitive agreements with an institutional investor for up to $1.1 billion in growth financing.
The SRFC team congratulates CEO Henry McPhie, Chairman Morgan Lekstrom, Chief Investment Officer Mitch Williams and the entire BioSig Technologies team on the transaction.
Cantor Fitzgerald & Co., Clear Street LLC and Needham & Company, LLC acted as placement agents for the transaction.
The SRFC team was led by partners Ross Carmel, Gregory Sichenzia, Barrett DiPaolo and Avital Perlman, with associates Christian Lichtenberg, Mohit Agrawal and Lony Leung.
